PortfoliosLab logoPortfoliosLab logo
DVA vs. FMS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

DVA vs. FMS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in DaVita Inc. (DVA) and Fresenius Medical Care AG & Co. KGaA (FMS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, DVA achieves a 84.56% return, which is significantly higher than FMS's 2.15% return. Over the past 10 years, DVA has outperformed FMS with an annualized return of 10.73%, while FMS has yielded a comparatively lower -3.31% annualized return.


DVA

1D
0.85%
1M
5.62%
YTD
84.56%
6M
79.97%
1Y
53.12%
3Y*
28.98%
5Y*
11.74%
10Y*
10.73%

FMS

1D
-0.85%
1M
8.09%
YTD
2.15%
6M
1.72%
1Y
-9.24%
3Y*
1.93%
5Y*
-7.90%
10Y*
-3.31%
*Multi-year figures are annualized to reflect compound growth (CAGR)

DVA vs. FMS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
DVA
DaVita Inc.
84.56%-24.03%42.75%40.30%-34.36%-3.10%56.47%45.80%-28.78%12.54%
FMS
Fresenius Medical Care AG & Co. KGaA
2.15%8.11%11.86%30.88%-48.42%-20.28%14.76%15.62%-37.60%25.49%

Correlation

The correlation between DVA and FMS is 0.45, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.45

Correlation (3Y)
Calculated over the trailing 3-year period

0.40

Correlation (5Y)
Calculated over the trailing 5-year period

0.43

Correlation (10Y)
Calculated over the trailing 10-year period

0.44

Correlation (All Time)
Calculated using the full available price history since Sep 19, 1996

0.29

The correlation between DVA and FMS shifts across timeframes, from 0.29 (all time) to 0.45 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

EPS

DVA:

$13.07

FMS:

€1.65

PE Ratio

DVA:

16.05

FMS:

12.39

PEG Ratio

DVA:

2.50

FMS:

0.46

PS Ratio

DVA:

0.91

FMS:

0.61

Total Revenue (TTM)

DVA:

$13.84B

FMS:

€19.36B

Gross Profit (TTM)

DVA:

$3.23B

FMS:

€5.03B

EBITDA (TTM)

DVA:

$2.49B

FMS:

€3.32B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

DVA vs. FMS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DVA
DVA Risk / Return Rank: 7777
Overall Rank
DVA Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
DVA Sortino Ratio Rank: 8383
Sortino Ratio Rank
DVA Omega Ratio Rank: 8181
Omega Ratio Rank
DVA Calmar Ratio Rank: 7272
Calmar Ratio Rank
DVA Martin Ratio Rank: 7171
Martin Ratio Rank

FMS
FMS Risk / Return Rank: 2929
Overall Rank
FMS Sharpe Ratio Rank: 2828
Sharpe Ratio Rank
FMS Sortino Ratio Rank: 2626
Sortino Ratio Rank
FMS Omega Ratio Rank: 2525
Omega Ratio Rank
FMS Calmar Ratio Rank: 3232
Calmar Ratio Rank
FMS Martin Ratio Rank: 3333
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DVA vs. FMS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for DaVita Inc. (DVA) and Fresenius Medical Care AG & Co. KGaA (FMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


DVAFMSDifference
Sharpe ratioReturn per unit of total volatility

+1.56

Sortino ratioReturn per unit of downside risk

+2.65

Omega ratioGain probability vs. loss probability

1.30

0.97

+0.34

Calmar ratioReturn relative to maximum drawdown

1.70

-0.31

+2.01

Martin ratioReturn relative to average drawdown

3.80

-0.54

+4.35

DVA vs. FMS - Sharpe Ratio Comparison

The current DVA Sharpe Ratio is 1.24, which is higher than the FMS Sharpe Ratio of -0.32. The chart below compares the historical Sharpe Ratios of DVA and FMS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

DVA vs. FMS - Drawdown Comparison

The maximum DVA drawdown since its inception was -92.91%, which is greater than FMS's maximum drawdown of -77.59%. Use the drawdown chart below to compare losses from any high point for DVA and FMS.


Loading charts...

Drawdown Indicators


DVAFMSDifference

Max Drawdown

Largest peak-to-trough decline

-92.91%

-77.59%

-15.32%

Max Drawdown (1Y)

Largest decline over 1 year

-31.36%

-29.82%

-1.54%

Max Drawdown (3Y)

Largest decline over 3 years

-41.43%

-40.49%

-0.94%

Max Drawdown (5Y)

Largest decline over 5 years

-51.10%

-68.67%

+17.57%

Max Drawdown (10Y)

Largest decline over 10 years

-51.10%

-75.61%

+24.51%

Current Drawdown

Current decline from peak

-0.43%

-49.70%

+49.27%

Average Drawdown

Average peak-to-trough decline

-20.04%

-23.83%

+3.79%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.01%

17.03%

-3.02%

Volatility

DVA vs. FMS - Volatility Comparison

DaVita Inc. (DVA) and Fresenius Medical Care AG & Co. KGaA (FMS) have volatilities of 7.45% and 7.84%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


DVAFMSDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.45%

7.84%

-0.39%

Volatility (6M)

Calculated over the trailing 6-month period

35.07%

24.10%

+10.97%

Volatility (1Y)

Calculated over the trailing 1-year period

43.08%

29.27%

+13.81%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

37.30%

32.15%

+5.15%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

34.76%

29.38%

+5.38%

Dividends

DVA vs. FMS - Dividend Comparison

DVA has not paid dividends to shareholders, while FMS's dividend yield for the trailing twelve months is around 3.73%.


PositionTTM20252024202320222021202020192018201720162015
DVA
DaVita Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FMS
Fresenius Medical Care AG & Co. KGaA
3.73%3.30%2.80%2.97%4.34%2.57%1.72%1.78%1.95%0.70%0.74%0.71%

Financials

DVA vs. FMS - Financials Comparison

This section allows you to compare key financial metrics between DaVita Inc. and Fresenius Medical Care AG & Co. KGaA. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


3.00B3.50B4.00B4.50B5.00B20222023202420252026
3.42B
4.61B
(DVA) Total Revenue
(FMS) Total Revenue
Please note, different currencies. DVA values in USD, FMS values in EUR

DVA vs. FMS - Profitability Comparison

The chart below illustrates the profitability comparison between DaVita Inc. and Fresenius Medical Care AG & Co. KGaA over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%5.0%10.0%15.0%20.0%25.0%30.0%35.0%202220232024202520260
25.6%
Portfolio components
DVA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, DaVita Inc. reported a gross profit of 0.00 and revenue of 3.42B. Therefore, the gross margin over that period was 0.0%.

FMS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Fresenius Medical Care AG & Co. KGaA reported a gross profit of 1.18B and revenue of 4.61B. Therefore, the gross margin over that period was 25.6%.

DVA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, DaVita Inc. reported an operating income of 481.89M and revenue of 3.42B, resulting in an operating margin of 14.1%.

FMS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Fresenius Medical Care AG & Co. KGaA reported an operating income of 375.56M and revenue of 4.61B, resulting in an operating margin of 8.1%.

DVA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, DaVita Inc. reported a net income of 197.53M and revenue of 3.42B, resulting in a net margin of 5.8%.

FMS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Fresenius Medical Care AG & Co. KGaA reported a net income of 119.94M and revenue of 4.61B, resulting in a net margin of 2.6%.


Frequently Asked Questions


DVA and FMS have a correlation of 0.45, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

FMS has higher volatility (7.84%) compared to DVA (7.45%). In terms of maximum drawdown, DVA dropped -92.91% vs FMS's -77.59%.

DVA currently has the higher Sharpe Ratio (1.24 vs -0.32), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for DVA and FMS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer